Moderna CEO not hopeful that vaccine will be able to cope with Omicron variant
The CEO of Moderna does not expect that existing vaccines will be as effective at dealing with the Omicron variant compared to earlier strains.
Stéphane Bancel also warned that it could take months before pharma companies bring new vaccines to the market which are specific to the new variant.
In January 2020, Moderna stock was $19 a share... it's $329 today.— Tim Young (@TimRunsHisMouth) November 26, 2021
That's all you need to know.
“There is no world, I think, where [the effectiveness] is the same level . . . we had with [the] Delta [variant],” Bancel told the Financial Times.
“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like, ‘This is not going to be good’,” he added.
Markets again spooked by Moderna CEO's self-serving comments which were identical to those given by the Chief Medial Officer two days earlier, confirm that algos have a 15 millisecond memory— zerohedge (@zerohedge) November 30, 2021
Bancel’s comments are somewhat at odds with those made by various public health experts and politicians, many of whom have been more positive about the ability of existing vaccines to deal with the Omicron variant.
For example, Joe Biden described the new variant as a “cause for concern” but not a “cause for panic”.
Fears over the impact of the new variant are growing, despite the lack of information thus far, which is delaying the scheduled reopening of economies around the world.
Is it possible #OmicronVariant sets us back to square one?— Ashish K. Jha, MD, MPH (@ashishkjha) November 28, 2021
We have lots of tests that'll detect Omicron
We have therapies that'll work
Our vaccines MAY take a hit but will still provide some (may be a lot) protection
We are in a MUCH better place
This isn't March 2020
Who knows what to believe anymore?